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ABSTRACT
The potential benefits and dangers of dietary protein restriction in chronic kidney disease (CKD)
are still controversial. Thus, the aim of this study is to evaluate the effect of low protein diet
(LPD) on the renal function in nondialysis CKD patients. A retrospective study was conducted
from 321 nondialysis CKD patient’s medical files (65.1± 12.7 yrs, 58.2% men). These patients
received individualized dietary protein prescription (0.6–0.8 g protein/kg/day). Protein intake was
evaluated by food diary and 24h-food recall. Adherence to the LPD was considered when
patients intake from 90 to 110% of the prescribed amount of protein. The patients were divided
into 4 groups: (G1) adherent diabetes mellitus (DM) patients (n¼ 83); (G2) non-adherent DM
patients (n¼ 106); (G3) adherent non-DM patients (n¼ 75); (G4) non-adherent non-DM patients
(n¼ 57). Renal function was assessed by estimated glomerular filtration rate (eGFR). Both groups
of patients (DM and non-DM) that adhered to the LPD showed significant improvement in eGFR
(G1: 38.7±13.2mL/min to 51.1±17.0mL/min (p< 0.001); G3: 35.1±16.8mL/min to 46.8±21.4mL/min
(p< 0.001)). In adherent patients, no differences in albumin and BMI were observed at the end
of follow up. In non-adherent patients, eGFR significantly decreased in DM group (G2:
44.2 ± 18.5mL/min to 38.2 ± 15.8mL/min (p¼ 0.003)). According to multivariate analysis, annual
changes in eGFR were not independent associated with age, gender, BMI, lipid profile, bicarbon-
ate or smoking status. In summary, adherence to low protein diet could be able to improve
serum creatinine and eGFR, well-known markers of renal function. However, prospective studies
are needed to control confounders which affect renal function and CKD progression.
ARTICLE HISTORY
Received 15 March 2016
Revised 28 December 2016
Accepted 9 January 2017
KEYWORDS
Chronic renal insufficiency;
adherence; protein-
restricted diet; glomerular
filtration rate
Introduction
For healthy adults, the Recommended Dietary Allowance
(RDA) for protein is 0.8 g/kg/day. This amount represents
dietary protein requirements (0.6g/kg/day) plus a per-
centage to achieve the safe intake1 and it is quite similar
to the recommendation for protein intake of nondialysis
chronic kidney disease (CKD) patients proposed by the
National Kidney Foundation (0.6 to 0.8 g protein/kg/
day).2 However, the term “low protein diet” (LPD) is used
to describe this recommendation because a diet
restricted to 0.6g protein/kg/day is 25% below the rec-
ommended (0.8 g protein/kg/day).3
The benefits of dietary protein restriction for nondial-
ysis CKD patients include reduction of hyperphosphate-
mia, metabolic acidosis, hyperkalemia and uremic
toxins that may suppress the appetite and stimulate
muscle protein wasting.2,4–6 However, the role of
dietary protein restriction in slowing CKD progression is
still controversial.4
Primary results of Modification of Diet in Renal
Disease (MDRD), the largest randomized clinical trial in
this matter, were not conclusive with regard to the
effectiveness of the LPD on CKD progression.7 However,
secondary analysis suggested many beneficial effects of
protein restriction.8 Thus, studies on the effects of LPD
in the CKD progression were performed and generated
non-conclusive or biased studies in part due to the diet
adherence,9–11 which is key to success.12,13
Although well-conducted randomized controlled tri-
als are best for studying short-term efficacy, observa-
tional studies may be more appropriate when
the intervention depends on the patient’s active partici-
pation.14 In practice, the long-term effects of LPD
should be evaluated face the adherence to the diet.12
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Poor adherence has been described8,11 and, conse-
quently, strategies to improve the LPD adherence, as
intensive nutritional counseling are highly recom-
mended.2 Thus, the aim of this study was to evaluate
the long-term effects of protein restriction on renal
function according the LPD adherence.
Methods
A retrospective analysis of 480 patients’ files attending
the conservative treatment from renal nutrition ambula-
tory of the Hospital da Lagoa (Rio de Janeiro, Brazil)
between June 2008 and January 2013 was performed.
The patients (without previous nutritional counseling)
were instructed to modify their intake of proteins,
sodium and phosphorus and, if necessary, caloric intake
in order to achieve the goals of the assigned diet.
Dietary instructions and the verification of adherence to
the prescribed diet were accomplished by a single
expert renal dietitian that followed all patients
included in the study at each CKD-clinical visit (every 3
months).
The inclusion criteria were age >18 years and esti-
mated glomerular filtration rate (eGFR)< 60mL/min.
The average follow-up was 3 years (ﬃ4 clinic visits per
year) and patients who were followed for less than
3 years, less than 4 visits per year and those who had
their treatment interrupted by absence during this
period were excluded. Moreover, patients with protein
intake less than 90% of dietary prescription were also
excluded. A total of 321 patients (65.1 ± 12.7 years of
age, 58.2% men) without renal disease etiology selec-
tion entered the study. The study protocol was
approved by the Ethics Committee of Medicine Faculty
of Federal University Fluminense (n. 144/11).
All participants received dietary counseling as recom-
mended by the Kidney Disease Outcomes Quality
Initiative nutritional guidelines (0.6–0.8 g/kg/day of pro-
tein and 30–35 kcal/kg/day of energy) [2]. The adher-
ence to dietary prescription was assessed by the 2 food
diary (1 weekday and 1 weekend, nonconsecutive),
where it was requested that the patient records all food
and beverages consumed, its specificities (e.g., skim
milk) and portions (in household measures, e.g., 1 cup
of 200mL). During nutritional consultations, the
patients completed a 24-h food recall. In this case,
patients were carefully instructed by the dietitian to
record all kinds and amounts of food (including bever-
ages) ingested, using measuring tools to estimate por-
tion sizes and to improve the accuracy of record.
Analyzes of these three food records were conducted
with software developed by the Universidade Federal
de S~ao Paulo – NutwinVR . The nutrient contents of foods
not contained in this software were searched on
Brazilian Table of Food Composition.15
Good adherence to LPD was defined as medium pro-
tein intake between 90 and 110% of dietary prescrip-
tion. To evaluate the understanding and motivation to
the diet, it was realized a self-report question which the
adherence was categorized as “excellent”, “very good”,
“fair” and “poor”. At each visit a complete clinical and
dietetic evaluation were performed and treatments
were adjusted. Thus, the 321 enrolled patients were div-
ided into 4 groups: Group 1: Diabetes mellitus (DM)
patients who adhered to the diet (n¼ 83); Group 2: DM
patients who did not adhered to the diet (n¼ 106);
Group 3: Non-DM patients who adhered to the diet
(n¼ 75); Group 4: Non-DM patients who did not
adhered to the diet (n¼ 57). Serum creatinine, urea,
albumin, lipid profile, and venous bicarbonate levels
were evaluated at baseline and every 3 months. For DM
patients, glucose and glycated hemoglobin (Hb) were
also determined at each 3 months. Serum albumin was
determined by bromocresol green method (normal
range: 3.5–4.8 g/dL). Body mass index (BMI) was calcu-
lated according to the formula: weight/(height2). Renal
function was expressed as eGFR, obtained by Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI)
creatinine equation,16 and the change of eGFR per year
was also calculated. Current smoking status was investi-
gated in Hospital database.
The Kolgomorov–Sminorv normality test was used to
characterize the data distribution. Results are presented
as mean± standard deviation, median (interquartile
range) or percentage, as applicable. Comparisons
between baseline and the follow-up data were analyzed
using paired t-test. For comparisons between independ-
ent groups, Student's t test, Chi-square or ANOVA test
were used. Multivariate regression analysis was per-
formed to verify variables independent associated with
annual changes in eGFR. Statistical significance was
accepted as p values <0.05.
Results
The percentage of patients who adhered to LPD diet
was 49.2% (25.8% DM and 23.4% non-DM). Age, gender,
and BMI were not different among 4 groups. At base-
line, creatinine levels and eGFR were not different
between G1 and G2 and also between G3 and G4.
Bicarbonate levels were lower in diabetic patients when
compared with non-diabetic patients (Table 1). The
hypertensive nephrosclerosis was the main etiology of
CKD in non-DM patients (87% and 90% in group 3 and
4, respectively). The group 4 presented higher preva-
lence of current smoking status (19%, p< 0.05) when
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compared with patients on G1 (4.8%), G2 (6.9%), and
G3 (8.3%).
The clinical and biochemical characteristics of
studied CKD patients are presented in Table 2. In adher-
ent patients (DM and non-DM), creatinine levels
decreased significantly after nutritional intervention
when compared with patients who did not adhered to
LPD. It was also observed increase in the eGFR after fol-
low-up nutritional counseling for patients who adhered
to the diet and the serum albumin levels remained
within normal values (>3.8 g/dL) in these patients. In
addition, there was no change in body weight in these
groups. Although non-significant, the albumin levels
were reduced and BMI increased in non-adherent
patients (G2 and G4) after follow-up (it was not
observed fluid overload in these patients).
Except in adherent non-diabetic patients (G3), ven-
ous bicarbonate showed significant increase in follow-
up time. Bicarbonate levels were not related to annual
changes in eGFR. The change of eGFR by year was stat-
istically different between adherent and non-adherent
patients (G1: 3.6 (5.5) mL/min/year; G2: 1.67 (5.8)
mL/min/year; G3: 4.4 (7.7) mL/min/year; G4: 1.33 (8.1)
mL/min/year; p< 0.0001 between groups G1 and G2;
G3 and G4). It was not observed statistical difference
in change of eGFR between G1 and G3; G2 and G4.
Multivariate regression analysis were performed to
evaluate the independent influence of variables pos-
sibly associated with progression of CKD (age, gender,
smoking status, BMI, cholesterol, triglycerides, high
density lipoprotein (HDL) and bicarbonate) on
annual changes of eGFR (Table 3). None of these varia-
bles was independent associated with change of eGFR
by year.
Discussion
We investigated the role of LPD adherence on renal
function during 3 years of intensive and specialized
nutritional counseling. The patients who adhered to the
LPD had significant improvement in creatinine, eGFR
and blood glucose and nutritional status maintenance.
On the other hand, patients with increased protein
intake had eGFR reduction at the end of follow-up (only
significant for DM patients).
The proposed mechanism by which the LPD can pre-
serve renal function includes reduction of glomerular
hypertension. A decrease in the glomerular capillary
pressure reduces glomerular sclerosis, renal fibrosis, and
proteinuria. In addition to this hemodynamic effect, the
dietary protein intake might affect the accumulation of
extracellular matrix protein directly or indirectly by
abnormal tubular protein in the kidneys.17,18 Recently,
an experimental study suggested that the renoprotec-
tive effect of the LPD could also be associated with the
attenuation of the renal mammalian target of rapamy-
cin (mTOR) pathway, a regulator of cellular protein syn-
thesis, and cell growth.19
In fact, meta-analyses of studies of the effects of pro-
tein restriction on CKD progression in diabetic and non-
diabetic patients showed beneficial results.8,9 However,
a main concern regarding LPD is the development of
protein energy wasting (PEW) with potential adverse
consequences, such as an increased risk of death.3,4 In
the present study, indicators of overall nutritional status
(BMI) and visceral protein and also mortality (albumin)
remained unaltered at the end of follow-up in the
adherent groups (DM and non-DM).
Corrected implementation of LPD, which includes
careful attention to amount of protein of high biological
Table 1. Baseline characteristics of CKD patients groups.
Group 1 Group 2 Group 3 Group 4
Sample size (n) 83 106 75 57
Age (years) 68.0 ± 11.2 63.2 ± 11.6 66.5 ± 13.4 63.0 ± 14.8
Gender (% men) 57 58.5 60 64
Creatinine (mg/dL) 1.91 ± 0.61a,b 1.90 ± 0.70c,d 2.20 ± 0.84 2.23 ± 0.81
eGFR (mL/min) 38.7 ± 13.2a,b 44.2 ± 18.5c,d 35.1 ± 16.8 35.1 ± 18.2
BMI (kg/m2) 25.8 ± 5.5 28.2 ± 5.6 27.2 ± 5.1 27.6 ± 5.8
Cholesterol (mg/dL) 187.8 ± 48.7 187.2 ± 51.5 192.7 ± 54.3 195.5 ± 47.9
Triglycerides (mg/dL) 158.9 ± 65.3 163.0 ± 94.9 151.8 ± 99.5e 221.5 ± 99.9
HDL (mg/dL) 42.0 ± 10.3 42.0 ± 9.6 45.3 ± 29.1 43.3 ± 13.6
Glycated Hb (%) 6.3 ± 1.1f 7.4 ± 1.4 – –
Bicarbonate (mM) 21.1 ± 2.4a,b 21.3 ± 1.7c,d 22.7 ± 2.3 22.3 ± 2.0
ap< 0.05 between G1 and G3.
bp< 0.05 between G1 and G4.
cp< 0.05 between G2 and G3.
dp< 0.05 between G2 and G4.
ep< 0.05 between G3 and G4.
fp< 0.05 between G1 and G2.
BMI: body mass index; eGFR: estimated glomerular filtration rate; HDL: high density lipoprotein; Hb: hemoglo-
bin. Group 1: DM (diabetes mellitus) patients who adhered to diet; Group 2: DM patients who not adhered
to diet; Group 3: Non-DM patients who adhered to diet; Group 4: Non-DM patients who not adhered to diet.
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value, proper energy intake and to other nutrients, such
as vitamins and micronutrients, is not able to induce
PEW.3,20 On the other hand, excess dietary protein can
have deleterious consequences, including accumulation
of uremic toxins, as P-cresyl-sulphate, responsible for
the well-known insulin resistance that occurs in many
patients even in early stages of CKD.20 Increasing pro-
tein in the diet also increases the phosphates and salt
intake as well as contributes to the generation of acid.
These factors could lead to hyperparathyroidism, hyper-
tension, loss of muscle mass and may even aggravate
progression of CKD.3–5,20,21
Despite the effectiveness and safety of LPD, the
adherence to the protein restriction is a key point on
the management of nondialysis CKD patients.12,13,22 In
the present study, demographic factors, such as age
and gender, seem not to affect the low protein diet
adherence. During the follow-up time, the dietitian
improved the nutritional approach to increase the LPD
adherence through some strategies: (a) adaptations in
usual diet to incorporate the protein restriction to habit-
ual meals and food habits (e.g., options for nocturnal
snacking are provided for patients with prefer do not
dining); (b) the use of replacement list of food to avoid
diet monotony (e.g., one egg can be substituted by half
steak portion); (c) use of portion sizes by measuring
tools (with use of replicas of food and kitchen utensils)
and photograph albums; (d) Analysis of the label of
foods to patients learned where find the data about
amount of protein per portion of processed foods;
(e) stimulation to improve the meals with specific
receipts of low protein content.23 In fact, to maintain the
LPD over time, the diet prescribed has to be pleasant,
varied and not too restrictive.12 Thus, the intensive coun-
seling (up to 3 months apart) by a skilled dietitian, as per-
formed in the present study, is highly recommended.2
The patients in groups G1, G2, and G4 had a signifi-
cant improvement in the venous bicarbonate levels dur-
ing the follow-up time. Curiously, non-diabetic LPD
adherent patients (G3) presented adequate bicarbonate
levels (>22mM) and they not presented increasing in
bicarbonate levels. This interesting feature could mean
that even those patients considered non-adherent to
LPD may have reduced their usual protein intake that
contributed to increment in the bicarbonate values in
G2 and G4 groups.
As well as protein intake, bicarbonate levels could be
associated with CKD progression.24 Thus, multivariate
analysis was performed to evaluate the association
between some variables and the annual changes on
eGFR. Age, gender, smoking status, BMI, lipid profile,
and bicarbonate were not independent associated with
changes in eGFR by year. Thus, protein intake could
be the responsible for improvement on creatinine
and eGFR in patients adherent to LPD (diabetics
Table 3. Regression analysis for the independent determi-
nants of annual changes in estimated glomerular filtration
rate.
Variable B coefficient Standard error p Values
Age 0.082 0.065 0.570
Gender 0.106 1.885 0.515
Smoking 0.081 3.056 0.572
Body mass index 0.171 0.176 0.277
Cholesterol 0.139 0.021 0.398
Triglycerides 0.146 0.009 0.369
High density lipoprotein 0.155 0.078 0.376
Glycated hemoglobin 0.125 0.667 0.411
Bicarbonate 0.044 0.379 0.772
Table 2. Anthropometric and biochemical data at the begin-
ning and at end of the follow-up period.
Groups Before After p Values
Group 1 (n¼ 83)
Creatinine (mg/dL) 1.91 ± 0.61 1.63 ± 0.72 0.002
eGFR (mL/min) 38.7 ± 13.2 51.1 ± 17.0 <0.001
Urea (mg/dL) 64.2 ± 13.2 60.9 ± 17.0 0.105
Albumin (g/dL) 4.1 ± 0.3 4.2 ± 0.2 0.413
BMI (kg/m2) 25.8 ± 4.4 25.9 ± 4.6 0.579
Cholesterol (mg/dL) 187.8 ± 48.7 183.1 ± 48.2 0.599
Triglycerides (mg/dL) 158.9 ± 65.3 155.6 ± 48.4 0.793
HDL (mg/dL) 42.0 ± 10.3 45.1 ± 11.1 0.183
Fasting glucose (mg/dL) 140.9 ± 69.9 113.1 ± 26.9 0.03
Glycated Hb (%) 6.3 ± 1.1 6.2 ± 1.0 0.527
Bicarbonate (mM) 21.1 ± 2.4 22.4 ± 1.4 <0.001
Group 2 (n¼ 106)
Creatinine (mg/dL) 1.90 ± 0.70 2.03 ± 0.71 0.153
eGFR (mL/min) 44.2 ± 18.5 38.2 ± 15.8 0.003
Urea (mg/dL) 76.6 ± 38.3 78.5 ± 31.4 0.302
Albumin (g/dL) 4.0 ± 0.3 3.7 ± 0.1 0.142
BMI (kg/m2) 28.2 ± 5.6 28.7 ± 5.9 0.489
Cholesterol (mg/dL) 187.2 ± 51.5 196.4 ± 50.1 0.200
Triglycerides (mg/dL) 163.0 ± 94.9 189.0 ± 99.9 0.260
HDL (mg/dL) 42.0 ± 9.6 40.6 ± 6.8 0.417
Fasting glucose (mg/dL) 142.0 ± 66.5 163.1 ± 61.8 0.089
Glycated Hb (%) 7.4 ± 1.4 7.2 ± 1.3 0.408
Bicarbonate (mM) 21.3 ± 1.7 23.1 ± 1.6 <0.001
Group 3 (n¼ 75)
Creatinine (mg/dL) 2.20 ± 0.84 1.82 ± 0.82 0.03
eGFR (mL/min) 35.1 ± 16.8 46.8 ± 21.4 <0.001
Urea (mg/dL) 70.9 ± 25.2 62.6 ± 26.3 0.05
Albumin (g/dL) 4.1 ± 0.4 3.9 ± 0.3 0.122
BMI (kg/m2) 27.5 ± 5.1 27.7 ± 5.5 0.545
Cholesterol (mg/dL) 192.7 ± 54.3 194.0 ± 38.6 0.680
Triglycerides (mg/dL) 151.8 ± 99.5 122.8 ± 61.0 0.200
HDL (mg/dL) 45.3 ± 29.1 46.3 ± 29.3 0.600
Bicarbonate (mM) 22.7 ± 2.3 22.6 ± 3.2 0.871
Group 4 (n¼ 57)
Creatinine (mg/dL) 2.23 ± 0.81 2.42 ± 1.04 0.136
eGFR (mL/min) 35.1 ± 18.2 33.7 ± 16.9 0.178
Urea (mg/dL) 70.9 ± 31.2 71.7 ± 31.5 0.267
Albumin (g/dL) 3.9 ± 0.4 3.2 ± 0.3 0.090
BMI (kg/m2) 27.6 ± 5.8 29.8 ± 6.0 0.101
Cholesterol (mg/dL) 195.5 ± 47.9 191.5 ± 29.6 0.367
Triglycerides (mg/dL) 221.5 ± 99.9 205.1 ± 63.0 0.657
HDL (mg/dL) 43.3 ± 13.6 41.8 ± 9.1 0.157
Bicarbonate (mM) 22.3 ± 2.0 23.3 ± 1.7 0.045
BMI: body mass index; eGFR: estimated glomerular filtration rate; HDL:
high density lipoprotein; Hb: hemoglobin. Group 1: DM patients who
adhered to diet; Group 2: DM patients who not adhered to diet; Group 3:
Non-DM patients who adhered to diet; Group 4: Non-DM patients who
not adhered to diet.
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and non-diabetics). However, the absence of data about
dietary protein intake (g/kg/day) is the main limitation
of the present study because avoid more accurate eval-
uations regarding independent factors associated with
CKD progression; or specific effects of protein intake
and clinical outcomes, such as bicarbonate levels.
Moreover, the present study has others limitations.
Firstly, the adherence to LPD was evaluated only by
dietary methods because the 24-h urinary urea nitrogen
excretion could not be determined due to logistical rea-
sons. Although not considered the gold standard, the
systematic use of dietary methods could be a strategy
to assess the feasibility of dietary interventions because
provides detailed intake data.25 Although dietary data
were collected, just the categorizing in “adherent” and
“nonadherent” patients is available. The availability of
original data would provide important information
about the real protein intake (g/kg/day) and its correla-
tions to other variables, such as serum bicarbonate lev-
els. Secondly, kidney function was estimated only
through eGFR (based on serum creatinine) because cys-
tatin C or others renal biomarkers are not available in
clinical practice. Thirdly, clinical outcomes closely
related to CKD progression (such as blood pressure con-
trol and proteinuria) could not be evaluated.
Consequently, the effects of LPD in the outcomes above
mentioned, as well as adjustments for all possible con-
founders could not be performed due to retrospective
study design. In this specific matter, randomized study
design had important ethical concerns because if LPD
promotes potential benefits to the nondialysis CKD
patients, should we randomize patients to a LPD or
unrestricted diet?14
Even with all these limitations, the present study
reports that low protein diet is nutritionally safe and
it could have a positive effect on the improvement
of creatinine and renal function in diabetics and non-
diabetics patients. Additionally, nutritional intensive
counseling is important to motivate the patients to
adhere to dietary protein restriction. However, con-
trolled studies are needed to evaluate the specific
effects of the protein restriction on glomerular filtration
rate and CKD progression.
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